Biogen Inc. Files Proxy Statement Addendum
Ticker: BIIB · Form: DEFA14A · Filed: Jun 2, 2025 · CIK: 875045
| Field | Detail |
|---|---|
| Company | Biogen Inc. (BIIB) |
| Form Type | DEFA14A |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, sec-filing, corporate-governance
TL;DR
Biogen dropped more proxy docs, no fee needed.
AI Summary
Biogen Inc. filed a Definitive Additional Materials (DEFA14A) document on June 2, 2025. This filing pertains to the company's proxy statement, indicating it's providing supplementary information to shareholders. The filing does not involve a fee, as indicated by the 'No fee required' checkbox.
Why It Matters
This filing provides additional information to Biogen's shareholders regarding matters to be voted on at their upcoming meeting, ensuring transparency in corporate governance.
Risk Assessment
Risk Level: low — This filing is a routine proxy statement addendum and does not contain new financial information or significant corporate actions that would immediately impact stock price.
Key Players & Entities
- BIOGEN INC. (company) — Registrant
- 225 BINNEY STREET (location) — Business Address
- CAMBRIDGE (location) — Business Address City
- MA (location) — Business Address State
- 02142 (location) — Business Address Zip
- 7814642000 (phone_number) — Business Phone
FAQ
What type of filing is this DEFA14A for Biogen Inc.?
This filing is classified as 'Definitive Additional Materials' (DEFA14A) for Biogen Inc.
When was this filing submitted to the SEC?
The filing was submitted on June 2, 2025.
Does Biogen Inc. have any former company names listed in this filing?
Yes, Biogen Inc. was formerly known as BIOGEN IDEC INC. and IDEC PHARMACEUTICALS CORP / DE.
What is Biogen Inc.'s fiscal year end?
Biogen Inc.'s fiscal year ends on December 31st.
Was there a filing fee associated with this DEFA14A submission?
No, the filing indicates 'No fee required'.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on June 2, 2025 regarding BIOGEN INC. (BIIB).